Teenagers are a high risk age group for meningitis and septicaemia and university freshers are particularly at risk because they mix with so many other students, some of whom are unknowingly carrying the bacteria.
The MenACWY vaccine helps to protect against four different types of meningococcal meningitis and septicaemia - Men A, C, W and Y. Young people up to the age of 20 and university freshers up to age 25 are advised to check their eligibility and get the vaccination whether starting university or not.
MRF’s eligibility checker makes it easy for anyone to find out if they are eligible to get the MenACWY vaccine free: www.meningitis.org/oneshot.
The symptoms can be similar to flu but become rapidly worse. Early symptoms are usually fever, vomiting, headache and feeling unwell. Limb pain, pale skin, and cold hands and feet often appear earlier than the rash, neck stiffness, dislike of bright lights and confusion.
Rob Dawson, Head of Support at MRF said, “We’re very grateful to Nick for taking on this huge challenge to raise funds. This will help support MRF’s lifesaving research into the prevention, detection and early treatment of meningitis and septicaemia. It will also allow us to continue supporting families affected by these devastating diseases.”